RevBio

RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology

Ziad2022-12-05T23:40:58-05:00 RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health. This funding will allow the company to pursue the treatment of wrist fractures with its patented bone adhesive technology known as Tetranite®. Read more >>

RevBio Awarded Funding to Conduct an In Vivo Bone Experiment on the International Space Station

Ziad2022-12-05T23:41:31-05:00 RevBio, Inc., announced that it has been awarded the opportunity to conduct an in vivo research experiment on the International Space Station U.S. National Laboratory (ISS National Lab). Read more >>

Sealing the Deal – Using Bone Glue to Treat Pain from Wisdom-Tooth Extractions

Ziad2022-12-05T23:41:19-05:00 For many teens, having one or more wisdom teeth removed is a health milestone after the first third molar teeth come in at the very back of the mouth and there isn’t enough room for them. But with this milestone also often comes another one – their first exposure to opioids. “Of about 10 million wisdom-tooth extractions done in a year, about a third come with a prescription for an opioid,” says George Kay, D.M.D., Chief Scientific Officer at the...

RevBio Enters the Animal Health Market to Help Improve Canine Dental Care

Ziad2022-12-05T23:41:36-05:00 As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of its innovative bone adhesive biomaterial to fill tooth extraction sockets in dogs in order to improve healing, maintain and support jaw thickness, and restore the structural stability which may help resist potential mandibular fractures. Read more >>

LaunchPad Medical Rebrands as RevBio and Launches an Updated Website

Ziad2022-11-25T14:02:28-05:00 Executives from LaunchPad Medical, Inc. announced that the company has rebranded. Its new name, RevBio, was chosen since it more accurately portrays the objective of developing its revolutionary Tetranite® bone adhesive biomaterial platform. Read more >>

LaunchPad Medical Initiates its First European Clinical Study

Ziad2022-11-25T14:02:28-05:00 LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study to examine the safety and efficacy of Tetranite®, the company's bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions. Read more >>

LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant

Ziad2022-11-25T14:02:29-05:00 LaunchPad Medical, Inc. announced that it has received follow-on support of up to $1.8 million from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center which was funded by the National Institute of Dental and Cranial Research (U24-DE029462) to improve the translation of promising tissue engineering and regenerative medicine technologies for dental, oral, and craniofacial clinical practice. Read more >>

LaunchPad Medical Wins a $2.5 Million NIH Grant to Improve Cranial Procedures

Ziad2022-11-25T14:02:38-05:00 LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. Read more >>

LaunchPad Medical Accelerates Enrollment in its First-In-Man Clinical Study

Ziad2022-11-25T14:02:40-05:00 LaunchPad Medical, Inc. announced that it has successfully enrolled half of the twenty patents approved by the FDA for its two-site pilot clinical study. This study constitutes the first clinical use of Tetranite®, a bone adhesive biomaterial. Read more >>

LaunchPad Medical Wins NIH HEAL Grant to Reduce Opioid Use and Addiction

Ziad2022-11-25T14:03:26-05:00 LaunchPad Medical, Inc. announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to improve strategies for the prevention and treatment for opioid misuse and addiction.Read more >>